FDA grants emergency use authorization to Eli Lilly's experimental COVID-19 antibody drug

INDIANAPOLIS - The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.…